Anifrolumab and deucravacitinib combo shows promise in patients with lupus Isra Zaman14 Nov 2022 9:30 AM ISTType I interferon (IFN) is a powerful immune activator that is present at high levels in the majority of patients with lupus, an autoimmune disease....
Lenabasum an effective and safe treatment for amyopathic dermatomyositis Dr. Kamal Kant Kohli2 Nov 2022 2:30 AM ISTLenabasum is a cannabinoid receptor type 2 agonist that triggers the resolution of inflammation. Researchers have found in a new study that Lenabasum...
Gut bacteria Prevotella copri may have potential role in evolution of preclinical RA Dr. Kamal Kant Kohli30 Oct 2022 7:30 PM ISTResearchers at the University of Colorado School of Medicine have discovered that Prevotella copri, a unique bacteria found in the gut could be...
Medical Bulletin 15/September/2022 Isra Zaman15 Sept 2022 4:19 PM ISTHere are the top medical news for the day:People with autoimmune disease have a higher complication rate after heart attack: StudyAfter a heart...
People with autoimmune disease have a higher complication rate after heart attack: Study Isra Zaman15 Sept 2022 9:00 AM ISTAfter a heart attack, people with an autoimmune disease were more likely to die, develop heart failure or have a second heart attack compared to...
Childhood Systemic Lupus Erythematosus: IAP Guidelines Ayesha Sadaf13 Aug 2022 11:00 AM ISTChildhood Systemic Lupus Erythematosus (cSLE) is a chronic heterogeneous autoimmune disease associated with considerable morbidity and significant...
Vit D supplements reduce autoimmune disease risk by 22%: VITAL trial Isra Zaman31 May 2022 9:30 AM ISTVitamin D supplementation for five years, with or without omega 3 fatty acids, reduced autoimmune disease by 22%. Omega 3 fatty acid supplementation...
Vitamin D and fish oil supplements may reduce risk of autoimmune disease, trial finds Dr. Kamal Kant Kohli27 Jan 2022 9:00 AM ISTA new study has revealed that Vitamin D and fish oil supplements may reduce risk of autoimmune disease.Taking daily vitamin D supplements - or a...
Takayasu arteritis during pregnancy tied to cesarean delivery and low birth weight babies: Study MD Editorial Team24 Nov 2021 9:00 AM ISTIreland: Takayasu's arteritis in pregnant women is associated with a high prevalence of adverse outcomes in both mother and the fetus, necessitating...
ChemoCentryx autoimmune disease drug Avacopan gets USFDA okay Medical Dialogues Bureau9 Oct 2021 1:37 PM ISTNew Delhi: ChemoCentryx said on Friday the U.S. health agency approved its lead drug for treating a rare, fatal autoimmune disease, sending the...
Rituximab superior to Mycophenolate mofetil for complete remission of Pemphigus Vulgaris: Study Dr. Shravani Dali8 July 2021 9:15 AM ISTRituximab showed better outcomes than mycophenolate mofetil in producing continued complete remission at 52 weeks in patients suffering from...
